These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19854252)

  • 41. Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.
    Tam JM; Engstrom JD; Ferrer D; Williams RO; Johnston KP
    J Pharm Sci; 2010 Jul; 99(7):3150-65. PubMed ID: 20187139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).
    Cocks E; Somavarapu S; Alpar O; Greenleaf D
    Pharm Res; 2014 Aug; 31(8):2000-9. PubMed ID: 24549823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
    Learoyd TP; Burrows JL; French E; Seville PC
    Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rejuvenated pressurised metered dose inhaler.
    Bell J; Newman S
    Expert Opin Drug Deliv; 2007 May; 4(3):215-34. PubMed ID: 17489650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
    Selvam P; El-Sherbiny IM; Smyth HD
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants.
    Tan Y; Yang Z; Peng X; Xin F; Xu Y; Feng M; Zhao C; Hu H; Wu C
    Int J Pharm; 2011 Jul; 413(1-2):167-73. PubMed ID: 21527322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
    Pu Y; Kline LC; Berry J
    Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
    Zhou QT; Morton DA; Yu HH; Jacob J; Wang J; Li J; Chan HK
    J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of expansion chamber geometry on atomization and spray dispersion characters of a flashing mixture containing inerts. Part II: High speed imaging measurements.
    Ju D; Shrimpton J; Bowdrey M; Hearn A
    Int J Pharm; 2012 Aug; 432(1-2):32-41. PubMed ID: 22579579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
    Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
    J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of co-grinding to formulate a model pMDI suspension.
    Williams RO; Repka MA; Barron MK
    Eur J Pharm Biopharm; 1999 Sep; 48(2):131-40. PubMed ID: 10469931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoglobulin G particles manufacturing by spray drying process for pressurised metered dose inhaler formulations.
    Carli V; Menu-Bouaouiche L; Cardinael P; Benissan L; Coquerel G
    Ann Pharm Fr; 2018 Jul; 76(4):291-298. PubMed ID: 29627069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
    Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
    Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.